Tower Research Capital (TRC)’s ABVC BioPharma ABVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $788 | Sell |
354
-2,222
| -86% | -$4.95K | ﹤0.01% | 4943 |
|
|
2025
Q1 | $2.73K | Buy |
2,576
+13
| +0.5% | +$14 | ﹤0.01% | 4515 |
|
|
2024
Q4 | $1.51K | Sell |
2,563
-60
| -2% | -$35 | ﹤0.01% | 5005 |
|
|
2024
Q3 | $1.79K | Sell |
2,623
-23
| -0.9% | -$16 | ﹤0.01% | 5100 |
|
|
2024
Q2 | $2.05K | Buy |
2,646
+126
| +5% | +$98 | ﹤0.01% | 5060 |
|
|
2024
Q1 | $3.3K | Buy |
2,520
+1,942
| +336% | +$2.54K | ﹤0.01% | 4887 |
|
|
2023
Q4 | $670 | Sell |
578
-2,407
| -81% | -$2.79K | ﹤0.01% | 5515 |
|
|
2023
Q3 | $3.1K | Buy |
2,985
+1,597
| +115% | +$1.66K | ﹤0.01% | 5052 |
|
|
2023
Q2 | $7.22K | Buy |
1,388
+63
| +5% | +$328 | ﹤0.01% | 4582 |
|
|
2023
Q1 | $8K | Sell |
1,325
-100
| -7% | -$604 | ﹤0.01% | 4603 |
|
|
2022
Q4 | $9K | Sell |
1,425
-85
| -6% | -$537 | ﹤0.01% | 4146 |
|
|
2022
Q3 | $13K | Buy |
1,510
+910
| +152% | +$7.83K | ﹤0.01% | 4250 |
|
|
2022
Q2 | $6K | Buy |
+600
| New | +$6K | ﹤0.01% | 4886 |
|
|
2021
Q4 | – | Sell |
-349
| Closed | -$8K | – | 6091 |
|
|
2021
Q3 | $8K | Buy |
+349
| New | +$8K | ﹤0.01% | 4512 |
|